Literature DB >> 26998263

Pleckstrin homology-like domain, family A, member 1 (PHLDA1) and cancer.

Maria Aparecida Nagai1.   

Abstract

Pleckstrin homology-like domain, family A, member 1 (PHLDA1) encodes a member of an evolutionarily conserved pleckstrin homology-related domain protein family. It was first identified as a potential transcription factor required for Fas expression and activation-induced apoptosis in mouse T cell hybridomas. The exact molecular and biological functions of PHLDA1 remain to be elucidated. However, its expression is induced by a variety of external stimuli and there is evidence that it may function as a transcriptional activator that acts as a mediator of apoptosis, proliferation, differentiation and cell migration dependent on the cellular type and context. Recently, PHLDA1 has received attention due to its association with cancer. In the present review, the current knowledge of PHLDA1 protein structure, expression regulation and function is summarized. In addition, the current data in the literature is reviewed with regards to the role of PHLDA1 in cancer pathogenesis.

Entities:  

Keywords:  PHLDA1; cancer; downregulation; oncogene; pleckstrin homology-like; stem cell; tumor suppressor gene

Year:  2016        PMID: 26998263      PMCID: PMC4774362          DOI: 10.3892/br.2016.580

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  46 in total

1.  Characterization and isolation of stem cell-enriched human hair follicle bulge cells.

Authors:  Manabu Ohyama; Atsushi Terunuma; Christine L Tock; Michael F Radonovich; Cynthia A Pise-Masison; Steven B Hopping; John N Brady; Mark C Udey; Jonathan C Vogel
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 2.  Allele-selective suppression of mutant genes in polyglutamine diseases.

Authors:  Chia-Rung Liu; Tzu-Hao Cheng
Journal:  J Neurogenet       Date:  2015-08-27       Impact factor: 1.250

3.  A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death.

Authors:  C G Park; S Y Lee; G Kandala; S Y Lee; Y Choi
Journal:  Immunity       Date:  1996-06       Impact factor: 31.745

4.  Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.

Authors:  Rüdiger Neef; Martina A Kuske; Elma Pröls; Judith P Johnson
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

5.  PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.

Authors:  Emmanuel O Johnson; Kuei-Hua Chang; Yolanda de Pablo; Soumitra Ghosh; Rutika Mehta; Sunil Badve; Kavita Shah
Journal:  J Cell Sci       Date:  2011-08-15       Impact factor: 5.285

6.  Inhibition of protein synthesis by the T cell receptor-inducible human TDAG51 gene product.

Authors:  T Hinz; S Flindt; A Marx; O Janssen; D Kabelitz
Journal:  Cell Signal       Date:  2001-05       Impact factor: 4.315

7.  Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation.

Authors:  Shufang Wu; Marie J Walenkamp; Arjan Lankester; Martin Bidlingmaier; Jan M Wit; Francesco De Luca
Journal:  J Clin Endocrinol Metab       Date:  2010-01-15       Impact factor: 5.958

8.  Transcriptional up-regulation of PHLDA1 by 17beta-estradiol in MCF-7 breast cancer cells.

Authors:  A C Marchiori; D A Casolari; M A Nagai
Journal:  Braz J Med Biol Res       Date:  2008-06-30       Impact factor: 2.590

9.  Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway.

Authors:  Amel Guezguez; Fréderic Paré; Yannick D Benoit; Nuria Basora; Jean-François Beaulieu
Journal:  Exp Cell Res       Date:  2014-02-15       Impact factor: 3.905

10.  TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.

Authors:  Michael D Oberst; Stacey J Beberman; Liu Zhao; Juan Juan Yin; Yvona Ward; Kathleen Kelly
Journal:  BMC Cancer       Date:  2008-07-02       Impact factor: 4.430

View more
  23 in total

1.  PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells.

Authors:  Naieli Bonatto; Maria José Carlini; Simone Aparecida de Bessa Garcia; Maria Aparecida Nagai
Journal:  Cell Adh Migr       Date:  2017-06-29       Impact factor: 3.405

2.  Comparative transcriptomic analysis of vascular endothelial cells after hypoxia/re-oxygenation induction based on microarray technology.

Authors:  Jia Xu; Jiu-Kun Jiang; Xiao-Lin Li; Xiao-Peng Yu; Ying-Ge Xu; Yuan-Qiang Lu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

3.  Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.

Authors:  Marta Viana-Pereira; Daniel Antunes Moreno; Paulo Linhares; Júlia Amorim; Rui Nabiço; Sandra Costa; Rui Vaz; Rui Manuel Reis
Journal:  Mol Biol Rep       Date:  2019-11-12       Impact factor: 2.316

4.  TDAG51-Deficiency Podocytes are Protected from High-Glucose-Induced Damage Through Nrf2 Activation via the AKT-GSK-3β Pathway.

Authors:  Chuntian Liu; Yanling Li; Xiaojuan Wang
Journal:  Inflammation       Date:  2022-02-17       Impact factor: 4.092

5.  Dynamic Interplay between Structural Variations and 3D Genome Organization in Pancreatic Cancer.

Authors:  Yongxing Du; Zongting Gu; Zongze Li; Zan Yuan; Yue Zhao; Xiaohao Zheng; Xiaochen Bo; Hebing Chen; Chengfeng Wang
Journal:  Adv Sci (Weinh)       Date:  2022-05-15       Impact factor: 17.521

6.  High-throughput functional evaluation of human cancer-associated mutations using base editors.

Authors:  Younggwang Kim; Seungho Lee; Soohyuk Cho; Jinman Park; Dongwoo Chae; Taeyoung Park; John D Minna; Hyongbum Henry Kim
Journal:  Nat Biotechnol       Date:  2022-04-11       Impact factor: 68.164

7.  DNA methylation alters transcriptional rates of differentially expressed genes and contributes to pathophysiology in mice fed a high fat diet.

Authors:  Pili Zhang; Tianjiao Chu; N Dedousis; Benjamin S Mantell; Ian Sipula; Lucy Li; Kimberly D Bunce; Patricia A Shaw; Liora S Katz; Jun Zhu; Carmen Argmann; Robert M O'Doherty; David G Peters; Donald K Scott
Journal:  Mol Metab       Date:  2017-02-03       Impact factor: 7.422

8.  Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy.

Authors:  Jinhui Wang; Feifei Wang; Jingbin Zhu; Mei Song; Jinghong An; Weimin Li
Journal:  J Mol Neurosci       Date:  2018-05-08       Impact factor: 3.444

Review 9.  PHLD Class Proteins: A Family of New Players in the p53 Network.

Authors:  Taylor T Fuselier; Hua Lu
Journal:  Int J Mol Sci       Date:  2020-05-17       Impact factor: 6.208

10.  Molecular processes mediating hyperhomocysteinemia-induced metabolic reprogramming, redox regulation and growth inhibition in endothelial cells.

Authors:  Michael Jan; Ramon Cueto; Xiaohua Jiang; Liu Lu; Jason Sardy; Xinyu Xiong; Justine E Yu; Hung Pham; Mohsin Khan; Xuebing Qin; Yong Ji; Xiao-Feng Yang; Hong Wang
Journal:  Redox Biol       Date:  2021-05-24       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.